All terms in HP
Label | Id | Description |
---|---|---|
Acute otitis media | HP_0000371 | [Acute otitis media is a short and generally painful infection of the middle ear.] |
Abnormal mannosylation of N-linked protein glycosylation | HP_0012355 | [An anomaly of the addition of mannose to N-linked glycans.] |
Abnormal protein N-linked glycosylation | HP_0012347 | [An anomaly of protein N-linked glycosylation, i.e., an abnormality of the protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via a nitrogen atom in an amino acid residue in a protein.] |
Increased fucosylation of N-linked protein glycosylation | HP_0012354 | [Increased addition of fucose sugar units to N-linked glycans.] |
Abnormal fucosylation of protein N-linked glycosylation | HP_0012352 | [An anomaly of the addition of fucose sugar units to N-linked glycans.] |
iron atom | CHEBI_18248 | [An iron group element atom that has atomic number 26.] |
iron group element atom | CHEBI_33356 | |
Decreased fucosylation of N-linked protein glycosylation | HP_0012353 | [Decreased addition of fucose sugar units to N-linked glycans.] |
Abnormal fucosylation of O-linked protein glycosylation | HP_0012359 | [An anomaly of the addition of fucose sugar units to O-linked glycans.] |
Abnormal protein O-linked glycosylation | HP_0012358 | [An anomaly of protein O-linked glycosylation, i.e., of the process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the hydroxyl group of a serine or threonine residue.] |
Abnormal protein glycosylation | HP_0012346 | [An anomaly of a protein glycosylation process, i.e., of a protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.] |
Increased mannosylation of N-linked protein glycosylation | HP_0012357 | [Increased addition of mannose to N-linked glycans.] |
dopamine | CHEBI_18243 | [Catechol in which the hydrogen at position 4 is substituted by a 2-aminoethyl group.] |
dopaminium(1+) | CHEBI_59905 | [An ammonium ion that is the conjugate acid of dopamine; major species at pH 7.3.] |
cardiotonic drug | CHEBI_38147 | [A drug that has a strengthening effect on the heart or that can increase cardiac output.] |
beta-adrenergic agonist | CHEBI_35522 | [An agent that selectively binds to and activates beta-adrenergic receptors.] |
dopaminergic agent | CHEBI_48560 | [A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.] |
sympathomimetic agent | CHEBI_35524 | [A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.] |
Decreased mannosylation of N-linked protein glycosylation | HP_0012356 | [Reduced addition of mannose to N-linked glycans.] |
Increased sialylation of N-linked protein glycosylation | HP_0012351 | [Increased addition of sialic acids to N-linked glycans.] |